Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.
Yale School of Medicine is launching a new study to investigate DotLab’s new noninvasive tests for endometriosis, based on blood and saliva samples. The study will evaluate the test’s ability to monitor ... Read more
The Institute for Clinical and Economic Review (ICER) recently released a draft evidence report assessing the clinical effectiveness and value of elagolix (ABT-620) for the management of endometriosis and ... Read more
Enteris BioPharma recently completed enrollment and initial dosing of all participants in an additional treatment arm of a Phase 2a clinical trial evaluating Ovarest, an oral leuprolide tablet, for ... Read more
Actress Julianne Hough is encouraging women with endometriosis to share their symptoms and push for better care by taking part in AbbVie’s SpeakENDO awareness campaign. The campaign is aimed at women who ... Read more
The Endometriosis Foundation of America is inviting all institutions and investigators conducting research in disease origin, diagnosis, treatment, epidemiology and the economic impact of endometriosis, among other topics, to apply for ... Read more
ObsEva announced the completion of patient enrollment in a Phase 2b clinical trial to evaluate OBE2109, an oral gonadotropin releasing hormone (GnRH) receptor antagonist, for the treatment of endometriosis-associated pain. ... Read more